Release Date: 26/07/17 09:38 Summary: Quarterly Activities Report, Appendix 5B Price Sensitive: No Download Document 1023.59KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%